Ebola laboratory preparedness at frontline hospitals: can we or can’t we?
Journal of Clinical Microbiology · 12.08.2026 · 64 (8)
DOI: 10.1128/jcm.00903-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.08.2026. Verfasst von Nicholas E Heger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola, Hospitals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Frontline hospitals are required to care for patients with suspected viral hemorrhagic fever (VHF), yet guidance on laboratory preparedness remains fragmented and incomplete. We conducted a multidisciplinary risk assessment of our institutional capacity to perform routine diagnostic testing for VHF persons under investigation (PUI), focusing on the feasibility of using automated core laboratory instruments. Our assessment revealed substantial gaps between CDC guidance (which permits core lab testing) and the practical ability to implement it safely. Public health mandates for VHF preparedness have not been accompanied by granular guidance on biosafety, laboratory infrastructure, or regulatory clarity necessary for implementation. Community hospitals, which would benefit most from safely using their existing automated core laboratory instruments, lack the infrastructure, staffing expertise, and clear guidance to do so, while well-resourced tertiary centers are often best positioned to develop dedicated point-of-care testing (POCT)-based workflows. Federal and state authorities must provide explicit, validated examples of acceptable mitigation strategies for testing using core lab instrumentation and reconcile conflicting recommendations across guidance documents. Without such authoritative clarity, frontline hospitals cannot confidently meet their mandated VHF preparedness obligations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
- Infection Prevention, Tufts Medical Center, Boston, Massachusetts, USA.
- Division of Geographic Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Zoe Freeman Weiss
Zitieren
APA
Heger, N. E., Fritschel, E., Nussbaum, E., Fraker, H., McCallum, J., Orr, B., Skahan, R., Minchello, E., Backman, M., Pilichowska, M., Morrow, M., Abedalthagafi, M., & Weiss, Z. F. (2026). Ebola laboratory preparedness at frontline hospitals: can we or can’t we?. Journal of Clinical Microbiology, 64(8). https://doi.org/10.1128/jcm.00903-26
Vancouver
Heger NE, Fritschel E, Nussbaum E, Fraker H, McCallum J, Orr B, et al. Ebola laboratory preparedness at frontline hospitals: can we or can’t we?. Journal of Clinical Microbiology. 2026;64(8). doi:10.1128/jcm.00903-26
BibTeX
@article{Heger2026,
author = {Heger, Nicholas E and Fritschel, Elyse and Nussbaum, Eliezer and Fraker, Hunter and McCallum, Justin and Orr, Beverley and Skahan, Robert and Minchello, Elaine and Backman, Melissa and Pilichowska, Monika and Morrow, Matthew and Abedalthagafi, Malak and Weiss, Zoe Freeman},
title = {Ebola laboratory preparedness at frontline hospitals: can we or can’t we?},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {8},
doi = {10.1128/jcm.00903-26}
}
EUVIMED